REG - Iofina PLC - Trading Update

IofinaAnnouncement

06/02/2023 07:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230206:nRSF9459Oa&default-theme=true

RNS Number : 9459O  Iofina PLC  06 February 2023

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS DEFINED IN ARTICLE 7 OF
REGULATION (EU) NO 596/2014 OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL OF
16 APRIL 2014 ON MARKET ABUSE (MARKET ABUSE REGULATION) AS RETAINED AS PART OF
UK LAW BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018 AS AMENDED.

 

6 February 2023

 

Iofina Plc

("Iofina" or the "Company")

(AIM: IOF)

 

 Trading Update

FY 2022 EBITDA expected to exceed market expectations

 

Iofina plc, specialists in the exploration and production of iodine and
manufacturers of specialty chemical products, provides the following trading
update.

 

Subject to the completion of the Company's full year audited results, which
are expected to be released in May 2023, Iofina is pleased to report that it
now expects its FY 2022 EBITDA(1) to be materially ahead of the previous
market forecast and no less than $10.5 million. Revenues for FY 2022 remain in
line with current guidance.

 

As noted in the Company's previous update on 11 January 2023, global demand
for both iodine and iodine-based derivatives were strong throughout 2022, with
prices rising during H1 2022 and remaining high in H2 2022. As a result, sales
margins achieved by Iofina in H2 2022 were robust and combined with our
improved iodine production, the Company delivered stronger second half
profitability than previously anticipated.

 

The Company also confirms that the construction of its newest IOsorb® plant,
IO#9, continues to progress within the expected timelines. Dirt work,
concrete, tanks placement and building structures are well underway.
Additionally, the items that will be repurposed from IO#5 have been dismantled
for use at IO#9. Business development opportunities for future iodine
production sites continue to progress positively.

 

The Company notes that iodine prices have remained steady into Q1 2023 and it
continues to see robust demand for its iodine and iodine derivatives.

 

Commenting, President and CEO of Iofina Dr. Tom Becker, stated: "2022 was a
year of significant progress for Iofina.  Solid iodine production
performance, higher prices and strong demand for iodine, and the beginning of
construction of our newest plant IO#9 are all examples of the positive
momentum that the Company is carrying forward into 2023.  The Board now
expects 2022 EBITDA to exceed market estimates and we look forward to
releasing the Company's fully audited 2022 results in May.  We are excited
for the commencement of production at our IO#9 plant later in Q2 2023 which is
anticipated to produce 100-150MT of crystalline iodine per annum."

 

 

(1) EBITDA is a non-IFRS measure and refers to Earnings Before Interest, Tax,
Depreciation and Amortisation.

 

Enquiries:

 

Dr. Tom Becker

CEO & President

Iofina plc

Tel: +44 (0)20 3006 3135

 

Nomad & Broker:

Henry Fitzgerald-O'Connor/Patrick Dolaghan/Andrew Potts

Canaccord Genuity Limited

Tel: +44 (0)20 7523 8000

 

Financial Adviser:

Kingsley Wilson

Chrystal Capital Partners LLP

Tel: +44 (0)20 7850 4761

 

Media Contact:

Charles Goodwin/Shivantha Thambirajah/Jazmine Clemens

Yellow Jersey PR Limited

Tel: +44 (0)7747 788 221/+44 (0)7983 521 488

About Iofina:

Iofina plc (AIM: IOF) is a vertically integrated company that specialises in
the production of Iodine and the manufacturing of specialty chemical products.
Iofina is the second largest producer of iodine in North America and operates
the manufacturing entities Iofina Resources and Iofina Chemical.

 

LEI: 213800QDMFYVRJYYTQ84

ISIN: GB00B2QL5C79

 

Iofina Resources

Iofina Resources develops, builds, owns and operates iodine extraction plants
using Iofina's WET® IOsorb® technology. Iofina currently operates five
producing IOsorb® plants in Oklahoma and is consistently using technology and
innovation to improve and expand its operations.

 

Iofina Chemical

Iofina Chemical has manufactured high quality halogen speciality chemicals
derived from raw iodine, as well as non-iodine based products.  Iofina
Chemical will be celebrating its 40(th) anniversary in 2023 as a preeminent
halogen-based specialty chemicals company.

 

www.iofina.com (http://www.iofina.com)

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  TSTVELFBXLLXBBQ